Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Middleton Fred A | Jun 25, 2026 | Buy | $200K | 248,972 |
| Director | Roberts Eric W | Sep 18, 2025 | Buy | $7.68K | 2,500 |
| Director | Roberts Eric W | Sep 15, 2025 | Buy | $9.1K | 3,400 |
| Director | Roberts Eric W | Sep 12, 2025 | Buy | $15.6K | 5,000 |
| Director | Roberts Eric W | Sep 9, 2025 | Buy | $7.38K | 2,343 |
| Director | Roberts Eric W | Aug 29, 2025 | Buy | $2.19K | 800 |
| Director | Roberts Eric W | Aug 28, 2025 | Buy | $26.34K | 9,200 |
| Director | Roberts Eric W | Aug 21, 2025 | Buy | $9.8K | 3,508 |
| Director | Roberts Eric W | Aug 20, 2025 | Buy | $5.44K | 2,000 |
| Chief Medical Officer | Hebbar Sudarshan | Aug 19, 2025 | Buy | $26.96K | 9,563 |
| Director | Roberts Eric W | Aug 19, 2025 | Buy | $2.79K | 1,000 |
| Director | Roberts Eric W | Aug 15, 2025 | Buy | $14.71K | 5,076 |
| Chief Medical Officer | Hebbar Sudarshan | Aug 15, 2025 | Buy | $12.27K | 4,392 |
| Chief Medical Officer | Hebbar Sudarshan | Aug 14, 2025 | Buy | $4.09K | 1,584 |
| Chief Scientific Officer | Stauderman Kenneth A. | Jul 28, 2025 | Buy | $3.96K | 1,000 |
| Chief Scientific Officer | Stauderman Kenneth A. | Jul 25, 2025 | Sell | $3.65K | 1,000 |
| Director | Roberts Eric W | Jul 22, 2025 | Buy | $5.66K | 1,500 |
| CEO | Leheny A. Rachel | Jul 21, 2025 | Buy | $3.4K | 1,000 |
| Director | Roberts Eric W | Jul 21, 2025 | Buy | $5.06K | 1,500 |
| Director | Roberts Eric W | Jul 18, 2025 | Buy | $5.76K | 2,000 |
| Director | WILSON ROBERT N | Jul 18, 2025 | Buy | $12.92K | 4,500 |
| CEO | Leheny A. Rachel | Jul 14, 2025 | Buy | $6.18K | 2,500 |
| Director | Roberts Eric W | Jul 14, 2025 | Buy | $15.81K | 6,500 |
| Director | Roberts Eric W | Jul 9, 2025 | Buy | $8.02K | 5,000 |
| Chief Scientific Officer | Stauderman Kenneth A. | Jul 1, 2025 | Buy | $1.85K | 1,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.